he Extra Income
Home
Blog
Portfolio BreakoutDetector & Stock Pick
Welcome back !
Newsletter 1
New articles, new ratings and a weekly summary of our stock picks
Newsletter 2
The 4% rule with New and closed positions, news and more
Very Important : You will receive our emails from the email address info@theextraincome.info or TheExtraIncomeStocks@gmail.com so be sure to remove this address from your black list or spam folder.
Celgene Corporation (CELG)


TEI Overall Rank
4/5



Margins :
5



Returns :
5



Debts :
2



Long Term Growth
5



Short Term Growth
4



TEI Ratio 4.17
Last Update 30.08.2018


Stock Chart



Warning: A non-numeric value encountered in /var/www/vhosts/gotrady.com/theextraincome.info/InternalPage.php on line 917

Warning: A non-numeric value encountered in /var/www/vhosts/gotrady.com/theextraincome.info/InternalPage.php on line 917

Warning: A non-numeric value encountered in /var/www/vhosts/gotrady.com/theextraincome.info/InternalPage.php on line 917

Warning: Division by zero in /var/www/vhosts/gotrady.com/theextraincome.info/InternalPage.php on line 932
Stock Price Details
Last Price:
Percent Change: 0
Volume:
Last Trade Date: 2020-04-01
Change from 52-week high:
Change from 52-week low:
P/E ratio:


Trend Details
Current trend (AI) ......


Company Details
Yield & Dividend: ......
EPS: ......


TEI Updates
30.08.2018kkkkkk
Ratings are changed as follow :
Rating of returns is not changed
Rating of debts is not changed
Rating of Margins is not changed
Short Term Growth from 5 to 4.
Long Term Growth from 4 to 5.
Overall rating is not changed
** If not reported with different note, we are tracking this stock since July 2015





With Bristol Myers' latest CAR-T filing, Celgene investors inch closer to payout - FierceBiotech
Posted on Wednesday April 01, 2020

Celgene CVR holders near finish line with bb2121 filing in U.S. - Seeking Alpha
Posted on Tuesday March 31, 2020

Bristol Myers nabs long-sought FDA nod for Celgene's MS drug ozanimod, but pandemic delays launch - FiercePharma
Posted on Thursday March 26, 2020

With latest FDA submission, Bristol Myers keeps pace with Celgene milestones - BioPharma Dive
Posted on Tuesday March 31, 2020

Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb - Yahoo Finance
Posted on Wednesday March 25, 2020

Recent Posts

December Report: Less fake signals, +140%. Breakout Detector.
Posted on Thursday January 02, 2020

October Report: 3+ trades with 20% return !
Posted on Friday November 01, 2019

September Report: +487%. HSY, YUM
Posted on Thursday October 03, 2019

August Report : Record HIT ! +769% in a month !
Posted on Thursday September 05, 2019

July Report : +513% and ANIK !!
Posted on Wednesday July 31, 2019


GuruFocus Articles
loading..